NCT02939118Completed
One-Year Follow-up Safety Study in Subjects Previously Implanted With VC-01™
A One-Year, Multicenter, Observational, Follow-up Safety Study in Subjects Previously Implanted With VC-01™ Combination Product
Source: ClinicalTrials.gov · Last updated 23 Apr 2024
Brief summary (registry, in English)
The purpose of this trial is to evaluate the long-term safety in subjects previously implanted with VC-01™ combination product.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 51 (actual)
- First submitted
- 18 Oct 2016
- Start date
- 7 Nov 2016
- Primary completion date
- 8 Feb 2024
- Lead sponsor
- ViaCyte
- Diseases
- Type 1 diabetes
- NCT number
- NCT02939118
What you commit to
- Study type: Observational
- Participants enrolled: 51
- From 7 Nov 2016 to the primary completion date, 8 Feb 2024
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- There are no exclusion criteria for this trial.
Who the study is looking for
- Previous implantation of VC-01™ combination product with subsequent explantation of all VC-01 units.
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.